Grassley Requests Hearing on 340B Prescription Drug Pricing Program in Light of GAO Report

July 17, 2015

The office of Senator Chuck Grassley of Iowa (7/17) has announced that Senator Grassley asked the leaders of the U.S. Senate Finance Committee to hold a hearing on the 340B Drug Pricing Program "in light of a report from the Government Accountability Office (GAO)" that recommended that Congress consider eliminating the "incentive to prescribe more drugs or more expensive drugs than necessary to treat Medicare Part B beneficiaries at 340B hospitals."